CVS Health Corporation (NYSE:CVS) has earned an average rating of “Buy” from the nineteen research firms that are presently covering the stock. Five research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $104.59.

CVS has been the subject of several recent research reports. Deutsche Bank AG increased their price target on CVS Health Corporation from $99.00 to $108.00 and gave the company a “hold” rating in a report on Wednesday, August 3rd. Zacks Investment Research raised CVS Health Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, August 3rd. FBR & Co reaffirmed an “outperform” rating and issued a $120.00 price target on shares of CVS Health Corporation in a report on Wednesday, August 3rd. Argus reaffirmed a “buy” rating and issued a $120.00 price target on shares of CVS Health Corporation in a report on Thursday, August 4th. Finally, Mizuho increased their price target on CVS Health Corporation from $108.00 to $111.00 and gave the company a “buy” rating in a report on Thursday, August 4th.

Hedge funds have recently bought and sold shares of the stock. Bridge Creek Capital Management LLC boosted its stake in CVS Health Corporation by 0.5% in the second quarter. Bridge Creek Capital Management LLC now owns 39,538 shares of the pharmacy operator’s stock worth $3,785,000 after buying an additional 179 shares in the last quarter. Ngam Advisors L.P. boosted its stake in CVS Health Corporation by 1.9% in the second quarter. Ngam Advisors L.P. now owns 233,294 shares of the pharmacy operator’s stock worth $22,336,000 after buying an additional 4,315 shares in the last quarter. BP PLC boosted its stake in CVS Health Corporation by 17.9% in the second quarter. BP PLC now owns 138,000 shares of the pharmacy operator’s stock worth $13,211,000 after buying an additional 21,000 shares in the last quarter. Retirement Systems of Alabama boosted its stake in CVS Health Corporation by 8.7% in the second quarter. Retirement Systems of Alabama now owns 1,043,349 shares of the pharmacy operator’s stock worth $99,890,000 after buying an additional 83,608 shares in the last quarter. Finally, Veritas Asset Management LLP boosted its stake in CVS Health Corporation by 10.1% in the second quarter. Veritas Asset Management LLP now owns 4,808,477 shares of the pharmacy operator’s stock worth $460,364,000 after buying an additional 439,848 shares in the last quarter. Institutional investors own 80.63% of the company’s stock.

Shares of CVS Health Corporation (NYSE:CVS) opened at 74.04 on Friday. CVS Health Corporation has a one year low of $69.30 and a one year high of $106.67. The stock has a market capitalization of $78.96 billion, a PE ratio of 15.87 and a beta of 0.88. The firm has a 50 day moving average price of $85.54 and a 200 day moving average price of $93.77.

CVS Health Corporation (NYSE:CVS) last announced its earnings results on Tuesday, November 8th. The pharmacy operator reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.57 by $0.07. CVS Health Corporation had a return on equity of 17.18% and a net margin of 2.96%. The business earned $44.60 billion during the quarter, compared to analysts’ expectations of $45.29 billion. During the same quarter in the prior year, the firm earned $1.28 earnings per share. The business’s revenue was up 15.5% compared to the same quarter last year. Analysts predict that CVS Health Corporation will post $5.81 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Thursday, November 3rd. Shareholders of record on Monday, October 24th were paid a $0.425 dividend. This represents a $1.70 dividend on an annualized basis and a yield of 2.30%. The ex-dividend date was Thursday, October 20th. CVS Health Corporation’s dividend payout ratio is presently 36.40%.

About CVS Health Corporation

CVS Health Corporation, together with its subsidiaries (CVS Health), is a pharmacy company. The Company operates through three business segments: Pharmacy Services, Retail/LTC and Corporate. The Company offers a range of products and services, such as advising patients on their medications at its CVS Pharmacy locations, introducing programs to help control costs for its clients at CVS Caremark, how care is delivered to its patients with conditions through CVS Specialty, pharmacy care for the senior community through Omnicare.

5 Day Chart for NYSE:CVS

Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.